Apollo

Apollo Neuro makes a wearable device that uses gentle, science-backed vibration patterns to train and rebalance the nervous system, helping users reduce stress, improve focus, relax, sleep better, and boost overall resilience without drugs by actively strengthening natural recovery processes.

Investment Details

Portfolia Fund

Funding Round

Series A

Milestones

Funded in 2022 and 2023

About the Founder

Kathryn Fantauzzi

Kathryn Fantauzzi is the co-founder and CEO of Apollo Neuroscience, leading the development of Apollo Neuro, a scientifically validated wearable that improves energy, focus, sleep, and stress resilience. She joined the original University of Pittsburgh research team in 2016 to fund clinical trials and bring the technology to market, launching Apollo Neuro in 2020. With a background in early stage technology commercialization, Kathryn is focused on translating proven science into real world wellbeing solutions.

Real Investors. Real Outcomes.

“I have learned so much about leadership, financial well-being, and the power of connection from the amazing community of women at Portfolia.”

Peggy Northrop

CEO of Watermark and Former Editor-in-Chief of More Magazine, Connecticut

“I love the concept of being able to invest and collaborate with others, mitigating my own risk by investing in a portfolio. It lets me see more deals in the pipeline.”

Chantell Preston

Healthcare Executive, Houston, TX

“I joined because I was excited that the model was more like a mutual fund and offered exposure to so many companies and opportunities to further learning.”

Namrita Kapur

Fellow, Yale School of Management, Boston, MA